Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 5
Results: 25
Atomoxetine hydrochloride.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 385, doi. 10.1038/nrd1387
- By:
- Publication type:
- Article
Monoclonal antibodies market.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 383, doi. 10.1038/nrd1386
- By:
- Publication type:
- Article
FDA HEAD WANTED, WIMPS NEED NOT APPLY.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 459, doi. 10.1038/nrd1396
- By:
- Publication type:
- Article
NEW HORIZONS IN CHEMICAL SPACE.
- Published in:
- 2004
- Publication type:
- Editorial
Current and future applications of the capsule camera.
- Published in:
- 2004
- By:
- Publication type:
- review
Prospects for productivity.
- Published in:
- 2004
- By:
- Publication type:
- research
IN BRIEFS.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 390
- Publication type:
- Article
KEY FACTORS IN THE RISING COST OF NEW DRUG DISCOVERY AND DEVELOPMENT.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 417, doi. 10.1038/nrd1382
- By:
- Publication type:
- Article
DISCOVERY AND DEVELOPMENT OF BEVACIZUMAB, AN ANTI-VEGF ANTIBODY FOR TREATING CANCER.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 391, doi. 10.1038/nrd1381
- Publication type:
- Article
DEVELOPMENT OF NOVEL TARGETED THERAPIES IN THE TREATMENT OF MALIGNANT GLIOMA.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 430, doi. 10.1038/nrd1380
- By:
- Publication type:
- Article
Metabolite-mediated misfolding.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 390, doi. 10.1038/nrd1391
- By:
- Publication type:
- Article
INFLAMMATORY RESOLUTION: NEW OPPORTUNITIES FOR DRUG DISCOVERY.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 401, doi. 10.1038/nrd1383
- By:
- Publication type:
- Article
New use for the cellular dustbin.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 389, doi. 10.1038/nrd1389
- By:
- Publication type:
- Article
Zebrafish reduce drug discovery gridlock.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 388, doi. 10.1038/nrd1398
- By:
- Publication type:
- Article
Plumbing for the heart.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 388, doi. 10.1038/nrd1392
- By:
- Publication type:
- Article
Timing is everything.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 387, doi. 10.1038/nrd1397
- By:
- Publication type:
- Article
AN AUDIENCE WITH ... Allen D. Roses.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 382, doi. 10.1038/nrd1400
- Publication type:
- Article
Patentability in the United States.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 381, doi. 10.1038/nrd1388
- By:
- Publication type:
- Article
Chiron claims against Genentech patent dismissed again.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1394
- Publication type:
- Article
Patent office decision over restriction requirement scrutinized.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1393
- Publication type:
- Article
No commercial break for combination treatment.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1390
- Publication type:
- Article
FDA publishes analysis of the pipeline problem.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 379, doi. 10.1038/nrd1404
- By:
- Publication type:
- Article
NEWS IN BRIEF.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 378
- Publication type:
- Article
Expanded EU presents promise and challenges.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 377, doi. 10.1038/nrd1403
- Publication type:
- Article
AMP KINASE AND MALONYL-COA: TARGETS FOR THERAPY OF THE METABOLIC SYNDROME.
- Published in:
- 2004
- Publication type:
- Correction Notice